Vynca Strengthens Leadership with Sandra Clarke's Addition to Board of Directors

Vynca Strengthens Leadership with Sandra Clarke's Appointment

In a significant move to enhance its leadership and commitment to transformative palliative care, Vynca, a prominent healthcare services and software company, has appointed Sandra Clarke to its Board of Directors as of June 2025. This appointment aims to bolster Vynca's mission of providing specialized care for individuals dealing with serious illnesses and complex health needs.

Sandra Clarke brings with her an impressive portfolio, boasting over 25 years of extensive experience in healthcare finance, operations, and transformation. She has previously made notable contributions in various high-profile roles at organizations such as Blue Shield of California, Daiichi Sankyo, and Philips Healthcare. Her track record for innovation and effective leadership aligns impeccably with Vynca's goal to improve the quality of life for patients facing serious health challenges.

Darren Schulte, M.D., the CEO of Vynca, expressed enthusiasm about Clarke’s appointment, asserting, “We are honored to welcome Sandra Clarke to our Board. Her exceptional background, particularly at Blue Shield of California, positions her perfectly to support our mission to enhance patient experiences while ensuring they can spend more quality time at home.” Vynca has a foundational commitment to utilizing predictive analytics and artificial intelligence to provide proactive care to seriously ill patients, which Clarke's extensive operational transformation experience will undoubtedly enhance.

Clarke’s most recent role was as Executive Vice President and Chief Operating Officer at Blue Shield of California, where she managed over $25 billion in annual revenue. During her tenure, she was pivotal in implementing innovative programs designed to rethink pharmacy care and significantly elevate the member experience. Clarke's strategic leadership played a crucial role in turning around the organization's financial standing, guiding it towards profitability and operational excellence.

Her prior positions at Daiichi Sankyo and Philips Healthcare included managing global teams and overseeing complex business operations, showcasing her capacity to lead and innovate within the healthcare sector. Notably, she has served on the boards of several healthcare organizations, providing her insights into audit, risk management, and governance.

Vynca is at a pivotal juncture in its journey. With Clarke's seasoned expertise, the organization looks forward to advancing its hybrid clinical model combining in-person and virtual support with predictive technology. This model is designed to facilitate early interventions, minimize avoidable hospital stays, and improve overall life quality for patients.

In her own words, Clarke stated, “I am honored to join Vynca's Board of Directors at such a pivotal time for the company and the field of palliative care. I understand the profound impact that specialty palliative care can have on patients, families, and the healthcare system. Vynca's technology-enabled, patient-centered approach is setting a new standard for quality and accessibility in serious illness care, and I look forward to supporting the company's mission.”

Clarke's inclusion in Vynca’s Board is a strategic reinforcement of the company as it seeks to expand its reach and influence in the nationwide delivery of high-quality, community-based palliative care and navigation.

About Vynca

Vynca is a health technology and services company dedicated to transforming care for individuals with serious and complex health needs. Through innovative palliative care solutions, intelligent care orchestration software, and robust care navigation strategies, Vynca empowers patients to enjoy a greater number of quality days at home. Their hybrid care model successfully integrates both virtual and in-person support while leveraging predictive analytics to ensure timely and effective interventions. For more information, visit Vynca's website.